4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001589776-26-000004
Director sold 15,545 shares at $10.29 ($159,958)
- Director acquired 15,545 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brughera Marco Maria Director | 2026-09-15 | Option exercise 10b5-1 | +15,545 | $2.11 | $32,800 | 15,545 | D: show line 1 in the form |
| Brughera Marco Maria Director | 2026-09-15 | Sale 10b5-1 | −15,545 | $10.29 | $159,958 | 0 | D: show line 2 in the form |
| Open-market sales · 15,545 sh · avg $10.29 · $159,958 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Brughera Marco Maria Director | 2026-09-15 | Option exercise · Stock Option 10b5-1 | −15,545 | 220,000 | D: show line 3 in the form |
Loading xslF345X06/form4-09162026_040901.xml…